EC
TMO icon

Enhancing Capital’s Thermo Fisher Scientific TMO Stock Holding History

Enhancing Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Hold
506
– – 0.18% 78
2025
Q4 		$293K Sell
506
-16
-3% -$9.05K 0.21% 78
2025
Q3 		$253K Buy
+522
New +$243K 0.19% 77
2025
Q2 		– Sell
-412
Closed -$205K – 94
2025
Q1 		$205K Buy
+412
New +$223K 0.16% 91

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Enhancing Capital's TMO Position: Q1 2026 in Review

Enhancing Capital held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 506 shares worth $249K. The position accounts for 0.18% of the portfolio, ranked #78.

Enhancing Capital first reported a position in TMO in Q1 2025 and has held it in 4 quarters since. The position peaked at $293K in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Enhancing Capital held 506 shares of Thermo Fisher Scientific worth $249K as of Q1 2026.
  • Enhancing Capital left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.18% of Enhancing Capital's portfolio in Q1 2026, its #78 holding.
  • Enhancing Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 4 quarters since.
  • Enhancing Capital's Thermo Fisher Scientific position peaked at $293K in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Enhancing Capital's 13F filing for Q1 2026, filed 8 May 2026.